Variants of concern responsible for SARS‐CoV‐2 vaccine breakthrough infections from India

Singh, Urvashi B. ; Rophina, Mercy ; Chaudhry, Rama ; Senthivel, Vigneshwar ; Bala, Kiran ; Bhoyar, Rahul C. ; Jolly, Bani ; Jamshed, Nayer ; Imran, Mohamed ; Gupta, Ritu ; Aggarwal, Praveen ; Divakar, Mohit K. ; Sinha, Subrata ; Arvinden, V. R. ; Bajaj, Anjali ; Shamnath, Afra ; Jain, Abhinav ; Scaria, Vinod ; Sivasubbu, Sridhar ; Guleria, Randeep (2021) Variants of concern responsible for SARS‐CoV‐2 vaccine breakthrough infections from India Journal of Medical Virology, 94 (4). pp. 1696-1700. ISSN 0146-6615

Full text not available from this repository.

Official URL: https://doi.org/10.1002/jmv.27461

Related URL: http://dx.doi.org/10.1002/jmv.27461

Abstract

Emerging reports of SARS-CoV-2 breakthrough infections entail methodical genomic surveillance for determining the efficacy of vaccines. This study elaborates genomic analysis of isolates from breakthrough infections following vaccination with AZD1222/Covishield and BBV152/Covaxin. Variants of concern B.1.617.2 and B.1.1.7 responsible for cases surge in April–May 2021 in Delhi, were the predominant lineages among breakthrough infections.

Item Type:Article
Source:Copyright of this article belongs to John Wiley & Sons, Inc.
ID Code:142454
Deposited On:21 Jan 2026 06:44
Last Modified:21 Jan 2026 06:44

Repository Staff Only: item control page